Skip to content

Author

Li-Chan Tao

We have 2 of 5 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Remnant cholesterol, C-reactive protein, cholesterol-lowering medication, and cardiovascular outcome: novel findings from UK Biobank

Despite substantial reductions in cardiovascular events with intensive LDL-C lowering, significant residual risk persists. Remnant cholesterol (RC) and C-reactive protein (CRP) reflect lipid dysregulation and inflammation, respectively, and may synergistically promote atherosclerosis. However, large-scale cohort ev...

Jing Chen, Xuan Song, Jian-Jun Li et al. · 0 citations
Open access Sep 2026

Lp(a), platelet count, aspirin and cardiovascular outcome: a prospective cohort analysis

Concomitant elevation of Lp(a) and platelet count identifies a subgroup of individuals at substantially higher risk for MACE, and the observed potential benefit of aspirin in the double-high subgroup is exploratory and warrants further prospective investigation.

Xuan-Ceng-Fan-Jiang Song, Jia-Xin Huang, Q. Hou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.